NEWS
Pharmaphorum I Chronic kidney disease: Challenges and upcoming technologies

As March has brought another National Kidney Month, and the recognition of World Kidney Day on March 9th, it is critical to take this opportunity to highlight the impact of kidney disease and to promote awareness and research, as more effective treatments are still needed.  According to the American Society of Nephrology (ASN), 850 million […]

The Medicine Maker I Flying with the FALCON

It was during my PhD in Pharmacology at UC San Diego that I found my desire to launch a biotech company. Amazed by the innovation in the local scene, I was itching to forge ahead – but I also knew that it would be wiser to learn the ropes of drug discovery and development first. […]

Reuters I SVB fall casts shadow on early-stage U.S. biotech

March 13 (Reuters) – The collapse of Silicon Valley Bank (SIVB.O) will leave early-stage biotechnology companies with a funding void, investors and analysts said on Monday, but larger, publicly-traded drug companies should escape unscathed. About 50% of U.S. biotech companies, developing drugs for everything from cancer to heart disease and rare conditions, banked with Silicon Valley Bank […]